REG - CVS Group plc - Transaction in Own Shares
Today 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251216:nRSP6712La&default-theme=true
RNS Number : 6712L CVS Group plc 16 December 2025
16 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 15 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 15/12/2025
Aggregate number of Ordinary Shares purchased: 16,820
Lowest price paid per share (GBp): 1,214.00
Highest price paid per share (GBp): 1,230.00
Volume weighted average price paid per share (GBp): 1,223.03
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,825,554 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,825,554 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 915,229 Ordinary Shares in aggregate at a weighted average price
of 1,215.93 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
200 1220 15/12/2025 08:23:50 1352082158261081 XLON
121 1226 15/12/2025 08:46:28 1352082158263562 XLON
100 1226 15/12/2025 08:46:28 1352082158263563 XLON
67 1226 15/12/2025 08:46:28 1352082158263564 XLON
198 1226 15/12/2025 08:46:28 1352082158263565 XLON
198 1226 15/12/2025 08:46:28 1352082158263566 XLON
63 1226 15/12/2025 08:46:28 1352082158263567 XLON
135 1226 15/12/2025 08:46:28 1352082158263568 XLON
198 1226 15/12/2025 08:46:28 1352082158263569 XLON
198 1226 15/12/2025 08:46:28 1352082158263570 XLON
198 1226 15/12/2025 08:57:09 1352082158264332 XLON
246 1226 15/12/2025 08:57:09 1352082158264334 XLON
198 1226 15/12/2025 08:57:09 1352082158264335 XLON
198 1226 15/12/2025 08:57:09 1352082158264336 XLON
336 1226 15/12/2025 08:57:09 1352082158264337 XLON
163 1226 15/12/2025 08:57:09 1352082158264338 XLON
35 1226 15/12/2025 08:57:09 1352082158264339 XLON
697 1226 15/12/2025 08:57:09 1352082158264340 XLON
198 1226 15/12/2025 08:57:09 1352082158264341 XLON
198 1226 15/12/2025 08:57:09 1352082158264342 XLON
198 1226 15/12/2025 08:57:09 1352082158264343 XLON
198 1226 15/12/2025 08:57:09 1352082158264344 XLON
198 1226 15/12/2025 08:57:09 1352082158264345 XLON
198 1226 15/12/2025 08:57:09 1352082158264346 XLON
198 1226 15/12/2025 08:57:09 1352082158264347 XLON
198 1226 15/12/2025 08:57:09 1352082158264348 XLON
92 1226 15/12/2025 08:57:09 1352082158264349 XLON
198 1226 15/12/2025 08:57:09 1352082158264350 XLON
23 1226 15/12/2025 08:57:13 1352082158264362 XLON
72 1224 15/12/2025 08:57:15 1352082158264368 XLON
76 1228 15/12/2025 09:10:09 1352082158265294 XLON
113 1228 15/12/2025 09:10:09 1352082158265295 XLON
174 1226 15/12/2025 09:10:54 1352082158265331 XLON
230 1226 15/12/2025 09:11:06 1352082158265341 XLON
71 1230 15/12/2025 09:17:05 1352082158265718 XLON
170 1228 15/12/2025 12:03:16 1352082158275298 XLON
120 1224 15/12/2025 12:08:12 1352082158275564 XLON
198 1224 15/12/2025 12:10:06 1352082158275713 XLON
108 1226 15/12/2025 12:20:05 1352082158276310 XLON
74 1226 15/12/2025 12:20:05 1352082158276312 XLON
198 1224 15/12/2025 12:47:23 1352082158277874 XLON
108 1230 15/12/2025 12:58:29 1352082158278710 XLON
71 1226 15/12/2025 13:29:26 1352082158280310 XLON
26 1224 15/12/2025 13:29:26 1352082158280311 XLON
172 1224 15/12/2025 13:35:19 1352082158280651 XLON
198 1224 15/12/2025 13:46:36 1352082158281295 XLON
74 1224 15/12/2025 13:46:36 1352082158281296 XLON
198 1224 15/12/2025 13:46:36 1352082158281297 XLON
198 1224 15/12/2025 13:46:36 1352082158281298 XLON
198 1224 15/12/2025 13:46:36 1352082158281299 XLON
198 1224 15/12/2025 13:46:36 1352082158281300 XLON
198 1224 15/12/2025 13:46:36 1352082158281301 XLON
198 1224 15/12/2025 13:46:36 1352082158281302 XLON
198 1224 15/12/2025 13:46:36 1352082158281303 XLON
198 1224 15/12/2025 13:46:36 1352082158281304 XLON
198 1224 15/12/2025 13:46:36 1352082158281305 XLON
198 1224 15/12/2025 13:46:36 1352082158281306 XLON
198 1224 15/12/2025 13:46:36 1352082158281307 XLON
198 1224 15/12/2025 13:46:36 1352082158281308 XLON
198 1224 15/12/2025 13:46:36 1352082158281309 XLON
198 1224 15/12/2025 13:46:36 1352082158281310 XLON
198 1224 15/12/2025 13:46:36 1352082158281311 XLON
198 1224 15/12/2025 13:46:36 1352082158281312 XLON
334 1224 15/12/2025 13:46:36 1352082158281314 XLON
85 1224 15/12/2025 13:46:36 1352082158281315 XLON
113 1224 15/12/2025 13:46:36 1352082158281316 XLON
5 1224 15/12/2025 13:46:36 1352082158281317 XLON
193 1224 15/12/2025 13:46:36 1352082158281318 XLON
5 1224 15/12/2025 13:46:36 1352082158281319 XLON
198 1224 15/12/2025 13:46:36 1352082158281320 XLON
107 1224 15/12/2025 13:46:36 1352082158281321 XLON
88 1220 15/12/2025 14:01:10 1352082158282331 XLON
116 1218 15/12/2025 14:02:21 1352082158282426 XLON
165 1218 15/12/2025 14:02:23 1352082158282441 XLON
107 1218 15/12/2025 14:30:28 1352082158284985 XLON
172 1216 15/12/2025 14:30:37 1352082158285034 XLON
74 1214 15/12/2025 14:35:16 1352082158285960 XLON
24 1214 15/12/2025 14:35:16 1352082158285965 XLON
176 1214 15/12/2025 14:35:19 1352082158285974 XLON
156 1214 15/12/2025 14:40:13 1352082158286880 XLON
480 1218 15/12/2025 14:57:23 1352082158289591 XLON
178 1218 15/12/2025 14:59:16 1352082158289738 XLON
296 1216 15/12/2025 15:13:03 1352082158292086 XLON
437 1214 15/12/2025 15:23:26 1352082158293712 XLON
53 1214 15/12/2025 15:23:26 1352082158293713 XLON
73 1214 15/12/2025 15:24:15 1352082158293825 XLON
82 1216 15/12/2025 15:34:45 1352082158295409 XLON
35 1216 15/12/2025 15:34:45 1352082158295410 XLON
71 1216 15/12/2025 15:36:51 1352082158295672 XLON
23 1218 15/12/2025 15:55:48 1352082158298643 XLON
9 1218 15/12/2025 15:57:07 1352082158298902 XLON
6 1218 15/12/2025 15:57:07 1352082158298903 XLON
1 1220 15/12/2025 16:14:57 1352082158302842 XLON
95 1220 15/12/2025 16:14:57 1352082158302843 XLON
198 1220 15/12/2025 16:17:12 1352082158303883 XLON
443 1220 15/12/2025 16:17:12 1352082158303886 XLON
396 1220 15/12/2025 16:17:13 1352082158303899 XLON
198 1220 15/12/2025 16:17:13 1352082158303900 XLON
125 1220 15/12/2025 16:17:15 1352082158303906 XLON
51 1220 15/12/2025 16:17:15 1352082158303907 XLON
12 1220 15/12/2025 16:17:15 1352082158303908 XLON
71 1220 15/12/2025 16:17:20 1352082158303976 XLON
198 1220 15/12/2025 16:17:20 1352082158303977 XLON
304 1222 15/12/2025 16:19:53 1352082158304759 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSGPGCAPUPAPWA
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Standard form for notification of major holdings
AnnouncementREG - CVS Group plc - Update on move to the Main Market
Announcement